Saudi Journal of Gastroenterology
Home About us Instructions Ahead of print Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 471 
September-October 2017 | Vol 23 | Issue  5     Table ofContents  RSS Feed 
 
 
Editorial
Failure of optimized dual proton pump inhibitor amoxicillin therapy: What now?
David Y Graham, Hong Lu, Akiko Shiotani
For a decade following the initial description of dual amoxicillin–proton pump inhibitor (PPI) therapy by Unge et al.,[1] investigators attempted to optimize the doses and duration of this regim...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
 
Systematic Review/Meta-analysis
Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis
Young-Sik Kim, Hoiseon Jeong, Jung-Woo Choi, Hwa Eun Oh, Ju-Han Lee
Background/Aim: Recently, AT-rich interactive domain-containing 1A protein (ARID1A) has been identified as a novel tumor suppressor gene in gastric cancer (GC) and colorectal canc...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
Original Article
Optimized high-dose amoxicillin–proton-pump inhibitor dual therapies fail to achieve high cure rates in China
Jia-Li Hu, Jun Yang, Yin-Bin Zhou, Ping Li, Ran Han, Dian-Chun Fang
Background\Aim: Quadruple daily administration of proton-pump inhibitor (PPI) therapy achieves potent acid inhibition, and combined with amoxicillin, with its pharmacodynamic and pharmacokineti...
[Abstract] | [HTML Full text] | [PDF] | [Mobile HTML Full text] | [EPub]
 
 
 
 

Read more....

     
 
Apply as Referee
Site Statistics

 Search Articles
 
    Advance Search

Submit Articles

Email Alerts

Join us

Pubmed